Canine ehrlichiosis vaccine developed in Israel

01/2/2013 | Israel21c

Veterinary researchers in Israel have developed the first vaccine for canine monocytic ehrlichiosis, a potentially deadly tick-borne disease that affects dogs. Although more research is needed to ensure that the vaccine protects against other strains, a commercial vaccine will likely be developed.

View Full Article in:

Israel21c

Published in Brief:

SmartBrief Job Listings for Retail

Job Title Company Location
Chief Information Officer
Total Wine & More
Potomac, Maryland
Human Resources Director, Distribution Services
Bed Bath & Beyond
Union, New Jersey
product guidance manager, Research & Development Sensory - Seattle, WA
Starbucks
Seattle, Washington
Retail Environmental Health and Safety Specialist
The Estee Lauder Companies
Production Coordinator
Tractor Supply Company
Brentwood, Tennessee